These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34357696)

  • 21. Coming Up Short: How Cancer Drug Shortages Affect Care.
    Verma N
    Health Aff (Millwood); 2024 Jun; 43(6):892-895. PubMed ID: 38830154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric oncology drug shortages: a multifaceted problem.
    Murphy D; Reaman G; Jensen CV
    Pediatrics; 2014 Mar; 133(3):e728-9. PubMed ID: 24488740
    [No Abstract]   [Full Text] [Related]  

  • 23. The shortage of drugs to treat pediatric malignancies: why does this happen?
    Kline NE
    J Pediatr Oncol Nurs; 2005; 22(6):303-4. PubMed ID: 16216892
    [No Abstract]   [Full Text] [Related]  

  • 24. Response to "Drug shortages and the burden of access to care: a critical issue affecting patients with cancer".
    Zweig PL; Campbell RA
    Clin J Oncol Nurs; 2014 Apr; 18(2):143-5. PubMed ID: 24809074
    [No Abstract]   [Full Text] [Related]  

  • 25. [Benefit-risk evaluation of new drugs as a basis for decisions on prioritization in hematology/oncology: methodical challenges and problem-solving strategies].
    Ludwig WD; Schildmann J
    Onkologie; 2011; 34 Suppl 1():6-10. PubMed ID: 21389762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Market access of cancer drugs in European countries: improving resource allocation.
    Pauwels K; Huys I; Casteels M; De Nys K; Simoens S
    Target Oncol; 2014 Jun; 9(2):95-110. PubMed ID: 24243526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The shortage of essential chemotherapy drugs in the United States.
    Gatesman ML; Smith TJ
    N Engl J Med; 2011 Nov; 365(18):1653-5. PubMed ID: 22040130
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemotherapy drug shortages in pediatric oncology: a consensus statement.
    Decamp M; Joffe S; Fernandez CV; Faden RR; Unguru Y;
    Pediatrics; 2014 Mar; 133(3):e716-24. PubMed ID: 24488741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology Group.
    G Salazar E; Bernhardt MB; Li Y; Aplenc R; Adamson PC
    Pediatr Blood Cancer; 2015 Jun; 62(6):940-4. PubMed ID: 25704486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom.
    Palmer DH; Hussain SA; Smith AJ; Hargreaves S; Ma YT; Hull D; Johnson PJ; Ross PJ
    Br J Cancer; 2013 Aug; 109(4):888-90. PubMed ID: 23880824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prioritization not Rationing in Cancer Care.
    Knoepffler N; Zerth J; O'Malley M
    Recent Results Cancer Res; 2019; 213():189-205. PubMed ID: 30543014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence-based practice in times of drug shortage.
    de Lemos ML; Waignein S; de Haan M
    J Oncol Pharm Pract; 2016 Jun; 22(3):566-70. PubMed ID: 26044588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Scoring Index of Prioritization Factors Between Patients: An Iberian Comparison.
    Pinho M; Borges AP
    Health Care Manag (Frederick); 2019; 38(3):267-275. PubMed ID: 31261196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer treatments rationed by authority.
    Halle M
    BMJ; 1996 Sep; 313(7060):774. PubMed ID: 8842067
    [No Abstract]   [Full Text] [Related]  

  • 35. From Choosing Wisely to Using Wisely: Increasing the Value of Cancer Care Through Clinical Research.
    Lichter AS
    J Clin Oncol; 2018 May; 36(14):1387-1388. PubMed ID: 29590009
    [No Abstract]   [Full Text] [Related]  

  • 36. Prioritization methods for HIV community planning.
    Johnson-Masotti AP; Pinkerton SD; Holtgrave DR
    J Public Health Manag Pract; 2000 Jul; 6(4):72-85. PubMed ID: 10977618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UK government moves to tackle lottery of cancer drugs.
    Burke K
    BMJ; 2004 Jun; 328(7454):1453. PubMed ID: 15205273
    [No Abstract]   [Full Text] [Related]  

  • 38. Cancer drug shortages lead to higher costs, greater risk.
    Printz C
    Cancer; 2013 Aug; 119(15):2667. PubMed ID: 23868455
    [No Abstract]   [Full Text] [Related]  

  • 39. Report highlights European inequalities in access to cancer drugs.
    Eur J Cancer; 2005 Dec; 41(18):2779. PubMed ID: 16408332
    [No Abstract]   [Full Text] [Related]  

  • 40. Differences in availability of cancer drugs across Europe.
    Mayor S
    Lancet Oncol; 2016 Sep; 17(9):1196. PubMed ID: 27476616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.